MoonLake Immunotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:MLTX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Apr 26	SellUS$2,752,163	Jorge da Silva	Individual	150,000	US$18.41
31 Mar 26	SellUS$62,962,500	BVF Partners L.P.	Company	3,750,000	US$16.79
09 Dec 25	SellUS$2,974,700	Jorge da Silva	Individual	200,000	US$15.08
09 Dec 25	SellUS$3,012,462	Kristian Reich	Individual	202,908	US$15.08
08 Oct 25	BuyUS$98,808	Matthias Bodenstedt	Individual	10,870	US$9.09
30 Sep 25	SellUS$18,548,556	Cormorant Asset Management, LP	Company	2,805,827	US$6.96
29 Sep 25	SellUS$28,319,628	Cormorant Asset Management, LP	Company	3,694,151	US$9.38

Insider Trading Volume

Insider Buying: MLTX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of MLTX?
Owner Type	Number of Shares	Ownership Percentage
General Public	2,210,477	3%
VC/PE Firms	6,408,863	8.71%
Individual Insiders	7,108,316	9.66%
Hedge Funds	20,481,717	27.8%
Institutions	37,406,023	50.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16%.

Top Shareholders

Top 25 shareholders own 79.23% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
21.7%	BVF Partners L.P.	16,001,284	US$284.0m	-19%	8.1%
8.71%	Deep Track Capital, LP	6,408,863	US$113.8m	39%	1.99%
6.09%	Cormorant Asset Management, LP	4,480,433	US$79.5m	2.87%	4.06%
4.69%	Janus Henderson Group plc	3,451,628	US$61.3m	64.7%	0.02%
4.09%	Kristian Reich	3,010,992	US$53.4m	0%	no data
3.97%	Jorge da Silva	2,924,893	US$51.9m	-4.88%	no data
3.25%	D. E. Shaw & Co., L.P.	2,390,661	US$42.4m	-3.63%	0.03%
2.46%	MPM BioImpact LLC	1,811,082	US$32.1m	0%	2.34%
2.32%	Weiss Asset Management, LLC	1,708,328	US$30.3m	413%	0.71%
2.04%	Logos Global Management, L.P.	1,500,000	US$26.6m	-14.3%	1.43%
1.86%	Point72 Asset Management, L.P.	1,368,518	US$24.3m	77.2%	0.04%
1.8%	Citadel Advisors LLC	1,323,728	US$23.5m	248%	0.02%
1.76%	T. Rowe Price Group, Inc.	1,294,861	US$23.0m	34.5%	no data
1.59%	Matthias Bodenstedt	1,172,431	US$20.8m	-8.14%	no data
1.54%	The Goldman Sachs Group, Inc.	1,130,233	US$20.1m	318%	0.01%
1.52%	Two Sigma Investments, LP	1,122,312	US$19.9m	43%	0.02%
1.45%	Balyasny Asset Management L.P.	1,065,610	US$18.9m	-32.2%	0.04%
1.39%	BlackRock, Inc.	1,021,851	US$18.1m	257%	no data
1.36%	Vivo Capital, LLC	1,000,000	US$17.7m	0%	1.63%
1.11%	Candriam, Société En Commandite Par Actions	818,126	US$14.5m	509%	0.04%
0.97%	Medical Strategy GmbH	717,589	US$12.7m	0%	0.81%
0.95%	JPMorgan Chase & Co.	697,814	US$12.4m	-16.7%	no data
0.94%	Bank of America Corporation	691,888	US$12.3m	83,400%	no data
0.83%	Morgan Stanley	609,084	US$10.8m	-41.4%	no data
0.82%	Holocene Advisors, LP	600,000	US$10.7m	0%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/12 21:57
End of Day Share Price	2026/06/12 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MoonLake Immunotherapeutics is covered by 16 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Julian Harrison	BTIG
Prakhar Agrawal	Cantor Fitzgerald & Co.
Samantha Lynn Semenkow	Citigroup Inc